ADAR1 Capital Management’s Janux Therapeutics JANX Stock Holding History

ADAR1 Capital Management’s Portfolio JANX Stock Details JANX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.15M	Buy	298,546 +53,094	+22%	+$728K	0.25%	87
2025 Q4	$3.39M	Sell	245,452 -105,580	-30%	-$2.48M	0.25%	71
2025 Q3	$8.58M	Buy	351,032 +288,944	+465%	+$7.04M	0.85%	29
2025 Q2	$1.43M	Sell	62,088 -91,679	-60%	-$2.42M	0.23%	69
2025 Q1	$4.15M	Buy	153,767 +122,258	+388%	+$4.61M	0.8%	37
2024 Q4	$1.69M	Buy	31,509 +18,509	+142%	+$979K	0.35%	56
2024 Q3	$591K	Buy	13,000 +5,109	+65%	+$222K	0.1%	105
2024 Q2	$331K	Sell	7,891 -6,109	-44%	-$287K	0.07%	120
2024 Q1	$527K	Buy	+14,000	New	+$305K	0.14%	80

Other funds holding JANX

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Janus Henderson Group

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Alyeska Investment Group

Alyeska Investment Group Chicago, Illinois $35.3B AUM 33.54% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return